Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)

Naomi A. Fineberg, Eric Hollander, Jon E. Grant, Samuel R. Chamberlain, Lynne M. Drummond, Luca Pellegrini, Keith R. Laws, David Wellsted, Jemma Reid, Vera Nezgovorova, David S. Baldwin

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number152323
JournalComprehensive Psychiatry
StatePublished - Jul 2022

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this